JP2012518646A5 - - Google Patents

Download PDF

Info

Publication number
JP2012518646A5
JP2012518646A5 JP2011551250A JP2011551250A JP2012518646A5 JP 2012518646 A5 JP2012518646 A5 JP 2012518646A5 JP 2011551250 A JP2011551250 A JP 2011551250A JP 2011551250 A JP2011551250 A JP 2011551250A JP 2012518646 A5 JP2012518646 A5 JP 2012518646A5
Authority
JP
Japan
Prior art keywords
blastomere
stem cells
drug according
cells
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011551250A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012518646A (ja
JP5809068B2 (ja
Filing date
Publication date
Priority claimed from US12/391,581 external-priority patent/US8563307B2/en
Application filed filed Critical
Publication of JP2012518646A publication Critical patent/JP2012518646A/ja
Publication of JP2012518646A5 publication Critical patent/JP2012518646A5/ja
Application granted granted Critical
Publication of JP5809068B2 publication Critical patent/JP5809068B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011551250A 2009-02-24 2010-02-19 免疫抑制−関連疾患の治療 Expired - Fee Related JP5809068B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/391,581 2009-02-24
US12/391,581 US8563307B2 (en) 2009-02-24 2009-02-24 Treatment of immunosuppression-related disorders
PCT/US2010/024735 WO2010099044A2 (en) 2009-02-24 2010-02-19 Treatment of immunosuppression-related disorders

Publications (3)

Publication Number Publication Date
JP2012518646A JP2012518646A (ja) 2012-08-16
JP2012518646A5 true JP2012518646A5 (enExample) 2012-11-29
JP5809068B2 JP5809068B2 (ja) 2015-11-10

Family

ID=42631141

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011551250A Expired - Fee Related JP5809068B2 (ja) 2009-02-24 2010-02-19 免疫抑制−関連疾患の治療

Country Status (7)

Country Link
US (2) US8563307B2 (enExample)
EP (1) EP2400971B1 (enExample)
JP (1) JP5809068B2 (enExample)
CN (1) CN102325537B (enExample)
ES (1) ES2582582T3 (enExample)
TW (1) TWI496888B (enExample)
WO (1) WO2010099044A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563307B2 (en) 2009-02-24 2013-10-22 James Wang Treatment of immunosuppression-related disorders
US8679474B2 (en) 2010-08-04 2014-03-25 StemBios Technologies, Inc. Somatic stem cells
WO2012054792A2 (en) * 2010-10-22 2012-04-26 Virginia Commonwealth University Composition and method for immunological treatment of cancer, prevention of cancer recurrence and metastasis, and overcoming immune suppressor cells
TWI614340B (zh) 2011-09-28 2018-02-11 幹細胞生物科技股份有限公司 體幹細胞及其製備方法
WO2013176785A1 (en) * 2012-05-21 2013-11-28 The Trustees Of Columbia University In The City Of New York Trefoil family factor and uses thereof
EP2929013B1 (en) 2012-12-06 2020-02-05 Stembios Technologies, Inc. Lgr5+ somatic stem cells
EP2746770A1 (en) * 2012-12-21 2014-06-25 Stembios Technologies, Inc. Method for evaluating effect of action on subject based on stem celldynamics
US9212225B1 (en) * 2014-07-01 2015-12-15 Amphivena Therapeutics, Inc. Bispecific CD33 and CD3 binding proteins
EA201792581A1 (ru) 2015-05-29 2018-07-31 Амфивена Терапьютикс, Инк. Способы применения биспецифических cd33- и cd3- связывающих белков

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2936171B2 (ja) 1989-09-01 1999-08-23 東ソー株式会社 血清アルブミンの製造方法
US6004807A (en) 1992-03-30 1999-12-21 Schering Corporation In vitro generation of human dendritic cells
US6916654B1 (en) * 1992-06-29 2005-07-12 Oklahoma Medical Research Foundation Universal donor cells
AU6869198A (en) * 1997-03-25 1998-10-20 Morphogenesis, Inc. Universal stem cells
AU1705599A (en) 1997-11-26 1999-06-15 Allegheny University Of The Health Sciences Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood
CA2347067C (en) 1998-03-31 2013-09-17 Geron Corporation Dendritic cell vaccine containing telomerase reverse transcriptase for the treatment of cancer
US6080399A (en) 1998-04-23 2000-06-27 Arch Development Corporation Vaccine adjuvants for immunotherapy of melanoma
JP3553858B2 (ja) 1999-08-25 2004-08-11 東洋紡績株式会社 血管網類似構造体を有する細胞培養用モジュール
US20030161817A1 (en) 2001-03-28 2003-08-28 Young Henry E. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
US7575921B2 (en) 1999-12-30 2009-08-18 Vbi Technologies, L.L.C. Spore-like cells and uses thereof
US20020151050A1 (en) 2000-10-30 2002-10-17 Vacanti Charles A. Isolation of spore-like cells from tissues exposed to extreme conditions
JP3977136B2 (ja) 2001-05-22 2007-09-19 キヤノン株式会社 コイルユニット
US7316932B2 (en) 2001-10-01 2008-01-08 Stemcell Technologies Inc. Method for separating cells
US7736892B2 (en) 2002-02-25 2010-06-15 Kansas State University Research Foundation Cultures, products and methods using umbilical cord matrix cells
WO2003075016A1 (en) 2002-03-07 2003-09-12 Cambridge University Technical Services Limited (Cuts) Scd fingerprints
DK1509244T3 (da) 2002-06-06 2011-10-24 Immunicum Ab Ny fremgangsmåde og præparat til at producere en cellulær allogen vaccine
WO2004042023A2 (en) * 2002-11-01 2004-05-21 Five Prime Therapeutics, Inc. Stem cell libraries
WO2004044158A2 (en) * 2002-11-08 2004-05-27 The Johns Hopkins University Human embryonic stem cell cultures, and compositions and methods for growing same
US20050003533A1 (en) 2003-05-08 2005-01-06 Pawel Kalinski Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use
US20090004661A1 (en) 2003-05-26 2009-01-01 Reliance Life Sciences Pvt Ltd. Method of growing mesenchymal stem cells from bone marrow
ES2265199B1 (es) 2003-06-12 2008-02-01 Cellerix, S.L. Celulas madre adultas multipotentes procedentes de condrocitos desdiferenciados y sus aplicaciones.
ES2433493T3 (es) * 2003-06-25 2013-12-11 Ottawa Hospital Research Institute Métodos y composiciones para modular el crecimiento de células pluripotenciales y la diferenciación
US7622108B2 (en) 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
ES2364878T3 (es) 2004-09-03 2011-09-15 Moraga Biotechnology Inc. Células madre de tipo blastómero totipotenciales no embrionarias y procedimientos de las mismas.
EP2410043A3 (en) 2004-12-29 2013-01-23 Hadasit Medical Research Services And Development Ltd. Stem cells culture systems
US8846395B2 (en) 2005-06-01 2014-09-30 Wisconsin Alumni Research Foundation Generation of mature myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+progenitors
US7651690B2 (en) 2005-06-24 2010-01-26 Desert Lake Technologies Purified component of blue-green algae and method of use
WO2007026353A2 (en) 2005-08-29 2007-03-08 Technion Research & Development Foundation Ltd. Media for culturing stem cells
US20080305079A1 (en) * 2006-01-06 2008-12-11 Mount Sinai School Of Medicine Of New York University Myeloid Suppressor Cells, Methods For Preparing Them, and Methods For Using Them For Treating Autoimmunity
CA2640087A1 (en) 2006-01-25 2007-08-02 Mount Sinai School Of Medicine Methods and compositions for modulating the mobilization of stem cells
US9617515B2 (en) 2006-02-27 2017-04-11 Moraga Biotechnology Corporation Non-embryonic totipotent blastomere-like stem cells and methods therefor
PL2032122T3 (pl) 2006-06-27 2016-12-30 Wyciągi z Aphanizomenonu Flos Aquae (AFA Klamath), aktywne związki i ich zastosowania
EP1894941A1 (en) * 2006-09-01 2008-03-05 Institut Pasteur Treatment of cervical carcinoma with a recombinant adenylate cyclase carrying HPV antigens
US8759090B2 (en) * 2006-10-30 2014-06-24 University Of Central Florida Research Foundation, Inc. Stem cell banking system
US20090155225A1 (en) 2006-11-02 2009-06-18 Mariusz Ratajczak Uses and isolation of very small of embryonic-like (vsel) stem cells
US20090104160A1 (en) 2007-02-01 2009-04-23 Moraga Biotechnology Corporation Mobilization of Stem Cells After Trauma and Methods Therefor
US20090053182A1 (en) 2007-05-25 2009-02-26 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same
EP3009148B1 (en) 2007-07-02 2018-08-22 Oncomed Pharmaceuticals, Inc. Compositions and methods for treating and diagnosing cancer
WO2009012357A2 (en) 2007-07-17 2009-01-22 The General Hospital Corporation Methods to identify and enrich for populations of ovarian cancer stem cells and somatic ovarian stem cells and uses thereof
MX2010000393A (es) 2007-11-09 2010-05-19 Rnl Bio Co Ltd Metodo para el aislamiento y cultivo de celulas madre adultas derivadas del epitelio amniotico humano.
EP2294185A2 (en) 2008-05-08 2011-03-16 Coretherapix Slu Multipotent adult stem cell population
WO2010039241A1 (en) 2008-09-30 2010-04-08 University Of Louisville Research Foundation, Inc. Methods for isolating very small embryonic-like (vsel) stem cells
WO2010056341A2 (en) 2008-11-12 2010-05-20 The University Of Vermont And State Agriculture College Compositions and methods for tissue repair
EP2387609B1 (en) 2009-01-13 2018-05-16 Stembios Technologies, Inc. Non-embryonic stem cells and uses thereof
PL3441458T3 (pl) 2009-02-03 2023-11-06 Koninklijke Nederlandse Akademie Van Wetenschappen Podłoże do hodowli nabłonkowych komórek macierzystych i organoidów zawierających wspomniane komórki macierzyste
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
US8563307B2 (en) 2009-02-24 2013-10-22 James Wang Treatment of immunosuppression-related disorders
US20140219952A1 (en) 2010-03-23 2014-08-07 The Johns Hopkins University Methods of treatment using stem cell mobilizers
CA2835313A1 (en) 2010-05-07 2011-11-10 Institut De Recherches Cliniques De Montreal Gfi1b modulation and uses thereof
WO2012019002A2 (en) 2010-08-04 2012-02-09 StemBios Technologies, Inc. Somatic stem cells
US8679474B2 (en) 2010-08-04 2014-03-25 StemBios Technologies, Inc. Somatic stem cells
CN102008650B (zh) 2010-12-16 2017-02-15 天津市医药科学研究所 一种治疗肿瘤的复方中药制剂及其制备方法
TWI614340B (zh) 2011-09-28 2018-02-11 幹細胞生物科技股份有限公司 體幹細胞及其製備方法
EP2929013B1 (en) 2012-12-06 2020-02-05 Stembios Technologies, Inc. Lgr5+ somatic stem cells
EP2818545A1 (en) 2013-06-24 2014-12-31 Stembios Technologies, Inc. Method for increasing number of stem cells in human or animal bodies
CN105687245A (zh) 2014-12-13 2016-06-22 干细胞生物科技公司 制备注射液的方法

Similar Documents

Publication Publication Date Title
JP2012518646A5 (enExample)
MX389346B (es) Formulaciones de anticuerpos monoclonales de alta concentración.
HRP20180237T4 (hr) Metode za liječenje hcv-a
JP2016517888A5 (enExample)
NZ707377A (en) Combination therapy methods for treating proliferative diseases
JP2016034978A5 (enExample)
MY180145A (en) Cenicriviroc compositions and methods of making and using the same
JP2014513722A5 (enExample)
RU2015103116A (ru) Новый штамм lactobacillus crispatus
EA201490377A1 (ru) Лечение рассеянного склероза комбинацией лаквинимода и глатирамера ацетата
PH12014501620A1 (en) Compositions and methods for the treatment of hepatic diseases and disorders
JP2011225596A5 (enExample)
MX388278B (es) Composiciones y metodos para inhibir masp-1 y/o masp-2 y/ o masp-3 para el tratamiento de la hemoglobinuria paroxistica nocturna
JP2016147915A5 (enExample)
IN2012DN06309A (enExample)
JP2016539156A5 (enExample)
JO3508B1 (ar) جهاز طبي محتوي على تركيبة عجينة مشتملة على أريببرازول كمكون فعال وتركيبة عجينة مشتملة على أريببرازول كمكون فعال
CO6771406A2 (es) Una composición combinada
JP2013541583A5 (enExample)
JP2016516985A5 (enExample)
RU2018125622A (ru) Способ применения карримицина против резистетности инфекции, спровоцированной микобактерией туберкулеза
MX2015016750A (es) Composicion inmunogenica para uso en terapia.
WO2012177660A3 (en) Leukotoxin e/d as a new anti-inflammatory agent and microbicide
EA201390417A1 (ru) Антидиабетические твердые фармацевтические композиции
JP2013100370A5 (enExample)